Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ·Healthcare·Biotechnology
$4.06
+6.71%
Mkt Cap $1.98B
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (9 analysts)
$5.30
Range $5.30 – $5.30
Implied Upside
+30.6%
Consensus $5.30 vs current $4.06
NASDAQ·Healthcare·Biotechnology
$4.06
+6.71%
Mkt Cap $1.98B
Buy
2
Hold
1
Sell
0
Price Target (9 analysts)
$5.30
Range $5.30 – $5.30
+30.6%
Consensus $5.30 vs current $4.06